We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tiziana Life Sciences Plc | LSE:TILS | London | Ordinary Share | GB00BKWNZY55 | ORD 3P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 58.50 | 45.00 | 60.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
12/2/2015 09:14 | tils 6.9% Tiziana Life Sciences Ord 3p Trades Date / Time Epic Price Type Quantity 12/02/2015 09:09:07 TILS 47.00 O 7,500 12/02/2015 08:54:42 TILS 46.50 O 2,500 12/02/2015 08:09:43 TILS 45.00 O 20,000 11/02/2015 16:25:54 TILS 43.50 O 3,000 Maybe the BBC programme last night on cancer and new drugs has boosted sector interest? | andrbea | |
22/12/2014 22:41 | Recommendation today for Tils from Beauforts. | share_shark | |
12/12/2014 17:59 | 👳 😴 🐄 🐑 🍷🍻 | impala391 | |
24/11/2014 14:48 | Most interesting SS, hope all goes well for you. regards ivor | rovi67 | |
21/11/2014 10:46 | Malta ? wow Malta ? your teasing, right! | rovi67 | |
12/11/2014 18:46 | Perhaps they found you in Monaco ss. Lol,. | impala391 | |
09/11/2014 16:17 | Thank you so much alby but it is a crime you know to sell what you are not entitiled to............ knowingly.: =) That doesn't say that I wish I could, especially with, the the amount they have allocated me. Doesn't add up, as usually it is only if you have a few left that they send the share cert. Oh well I will frame the cert on the wall...........where I cannot see it. Best wishes to you all and alby and hope the employment prospects are great for you now. | share_shark | |
09/11/2014 09:28 | No I have not SS up to now. Best advice I would SELL THEM !! RGT and various rampers, robbed us blind so call it a bonus/payback. | alby220 | |
09/11/2014 01:58 | Has any RGT shareholder received a share cert for TILS, which they are not entitled to ?. I have a cert, for a load of them. If I were entitled to the shares, surely they would have gone straight to my broker and not to me,,,,,,,,unless they were a minute amount?. I sold my ADI free shares, which we received on a one for one basis for our RGT holdings and then bought and traded ADI again, as you all know, when Paul Johnson began to buy. I have sent the TILS share cert back and they have returned them saying they ARE mine, when I darn well know they are not. I have spoken to my broker, who can prove I am not entitled to the TILS shares but its going to be difficult getting my accountant to deal with HMRC. Perhaps they will think I am living a double life, under an assumed name, in somewhere like Switzerland or France ...............lying low, so to speak from the illicit takings from drug dealing or the remains of the Brinks Matt bullion raid !. If the same thing has happened to anyone else ,perhaps you could post here please. TIA | share_shark | |
21/10/2014 12:34 | A recording of the recent webinar is now available on our website and YouTube. Registration is free. Kind Regards, Equity Development | hannahh | |
17/10/2014 13:18 | If you're interested in listening to the management present their interim results and asking them questions feel free to join them on Monday for a webinar at 10.30am (20th October). Follow this link to register: Kind Regards, Equity Development | hannahh | |
16/10/2014 18:39 | looks like none of RGT'ers know what to make of this. | stav5001 | |
15/10/2014 16:58 | God what's going here, I've been diluted down from ADI but this seems to float. Is there news soon ? | stenick | |
03/10/2014 18:50 | Rovi sssssh ss may go to sleep now . | impala391 | |
01/10/2014 16:08 | the doom has worn off, greattttttt | rovi67 | |
01/10/2014 11:43 | Oh No! SS has posted and we went down right after. Dratttttttt Lol | rovi67 | |
01/10/2014 09:09 | Recommendation on TILS , from Beauforts today. The Markets Market opening: Markets are likely to open lower today. FTSE 100 futures were trading 29.0 points down at 7:00 am. New York: Wall Street declined amid quarter-end repositioning by portfolio managers. S&P closed 0.3% lower on Tuesday, majorly impacted by decreasing energy share prices. The index shed 1.6% in September. Asia: Markets are reporting losses as investors focus on political turmoil in Hong Kong and consider official Chinese PMI data. Nikkei closed 0.6% lower, whereas Hang Seng was closed for a holiday. Continental Europe: Equities rose as investors largely ignored the geopolitical crisis in Hong Kong and shifted focus to the upcoming European Central Bank meeting on Thursday. France’s CAC 40 and Germany’s DAX gained 1.6% and 0.6%, respectively. Crude Oil: Yesterday, the prices of WTI and Brent crude oil fell 3.6% and 2.6%, respectively. The spread between the two varieties stood at US$3.5 per barrel. UK small caps: The FTSE AIM All-Share index closed 0.07% higher yesterday at 750.08. To read our latest research click here. Today's breakfast menu: - Beaufort Securities on Tiziana Life Sciences - Speculative Buy; Rose Petroleum - Speculative Buy; W Resources - Speculative Buy; Angle - Speculative Buy; Northcote Energy - Speculative Buy and Haydale Graphene Industries - Spec Buy - UK Nationwide house prices; Germany’s unemployment change; UK GDP; Eurozone CPI and US consumer confidence index | share_shark | |
16/9/2014 21:49 | VIDEO Niall Pearson from AIM broker and adviser Hybridan LLP ‘record-breaki - Today, 9:48 PM | firefox6 | |
13/9/2014 16:48 | I like they have got a bonus rather than diluting the share issue. | impala391 | |
12/9/2014 10:00 | so new bloke on Advisory Board has the pedigree alright (see mkt cap of his start-ups): Professor Pellicciari was the co-founder and remains Head of Medicinal Chemistry at Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) ("Intercept"), a clinical stage biopharmaceutical company focused on the development and commercialisation of novel bile acid therapeutics to treat chronic liver and intestinal diseases. Intercept currently has a market capitalisation of approximately US$6.15 billion. | andrbea | |
11/9/2014 17:20 | Well they raise the price when you sell and lower the price when you buy!!!😎 | impala391 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions